share_log

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga ·  Nov 6 20:05

Gainers

  • Regenxbio (NASDAQ:RGNX) stock increased by 16.6% to $10.4 during Wednesday's pre-market session. The market value of their outstanding shares is at $514.0 million. As per the press release, Q3 earnings came out today.
  • Tango Therapeutics (NASDAQ:TNGX) shares increased by 15.83% to $6.0. The market value of their outstanding shares is at $642.8 million.
  • Macrogenics (NASDAQ:MGNX) shares increased by 15.11% to $4.34. The company's market cap stands at $272.2 million. As per the news, the Q3 earnings report came out yesterday.
  • Xylo Technologies (NASDAQ:XYLO) stock rose 14.4% to $3.97. The market value of their outstanding shares is at $7.5 million.
  • Globus Medical (NYSE:GMED) shares moved upwards by 13.77% to $85.99. The market value of their outstanding shares is at $11.6 billion. As per the press release, Q3 earnings came out yesterday.
  • Processa Pharma (NASDAQ:PCSA) stock increased by 13.63% to $1.25. The company's market cap stands at $4.0 million.

Losers

  • Exact Sciences (NASDAQ:EXAS) stock decreased by 26.6% to $52.5 during Wednesday's pre-market session. The company's market cap stands at $9.7 billion. As per the press release, Q3 earnings came out yesterday.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares declined by 24.53% to $0.1. The company's market cap stands at $1.7 million.
  • Altamira Therapeutics (NASDAQ:CYTO) stock declined by 21.16% to $0.41. The market value of their outstanding shares is at $1.5 million.
  • PACS Group (NYSE:PACS) shares decreased by 20.49% to $23.49. The market value of their outstanding shares is at $3.6 billion.
  • Evotec (NASDAQ:EVO) stock fell 19.66% to $3.68. The company's market cap stands at $1.3 billion. As per the press release, Q3 earnings came out today.
  • Bionomics (NASDAQ:BNOX) shares declined by 15.93% to $0.41. The market value of their outstanding shares is at $5.4 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment